Navigator Medicines
PrivateLast Round
Seed Round
Sep 25, 2026
Est. Valuation
$154M
Total Funding Raised
$100M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Navigator Medicines is a biotechnology company that develops bispecific antibody therapies for the treatment of complex autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Navigator Medicines Comparables
Compare Navigator Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IMBiologics | 83% | |
| ImageneBio, Inc. | 75% | |
| Amgen | 73% |
Navigator Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Sep 25, 2026 | ||||
| Series A | Aug 27, 2024 |
Navigator Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| Forbion | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 25, 2026
Raised $10M in Seed funding.
- Jun 1, 2026
Grew 23% QoQ, from 22 to 27 employees.
Recent news
Latest coverage and updates
- attends_eventSep 29, 2026
Navigator Medicines, Inc. attends event EADV 2026.
- attends_eventSep 29, 2026
Navigator Medicines, Inc. attended event EADV Congress on Jul 1st '26.
- is_developingSep 26, 2026
Navigator Medicines, Inc. is developing longer-lasting NAV-242
Navigator Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Navigator Medicines's valuation, stock price, and market status.
Is Navigator Medicines a public or private company?
Navigator Medicines is a private company.
What is the current stock price of Navigator Medicines?
Navigator Medicines is a private company, so its shares have no public market price. Caplight tracks Navigator Medicines's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Navigator Medicines worth (valuation)?
Navigator Medicines's valuation is estimated at $154.0M based on funding round data.
Can I buy Navigator Medicines stock?
Navigator Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Navigator Medicines's last funding round?
Navigator Medicines's most recent funding round was Seed Round on September 25, 2026.
Who are the main investors in Navigator Medicines?
Key investors in Navigator Medicines include RA Capital Management, Forbion.
Will Navigator Medicines IPO soon?
No public IPO plans have been announced for Navigator Medicines.
How can I track Navigator Medicines secondary market activity?
Caplight tracks bids, offers, and trades in Navigator Medicines's shares on secondary markets.